Korean drugmakers look to rapidly growing orphan drug market

Published: 2008-12-03 06:48:00

Updated: 2008-12-03 06:48:00

The total worldwide market for orphan drugs is expected to rise at an AAGR (average annual growth rate) of 9.1% to reach $43.6 billion in 2008, according to market experts.

The future of the orphan drug industry will depend heavily upon the entry of biogenerics, since biologics account for ove...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK